Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NRC HEALTHNRC · Entity 5534 | Director · Chairman | January 05, 2026 | January 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NRC HEALTH
Report date January 05, 2026 · Filed January 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,154 |
Reported balance
After 2026-01-05 transaction · row 1
1 source rowRow 1 · 2026-01-05 · Exercise / conversion · Acquired 9,145 · Balance 20,154 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.23 · Expires 2026-01-05 | Direct | 0 |
Reported balance
After 2026-01-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-01-05 · Exercise / conversion · Disposed 9,145 · Balance 0 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 76,095 |
Reported balance
Holding disclosure · report date 2026-01-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 76,095 F1: The reporting person disclaims beneficial ownership of these shares. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person disclaims beneficial ownership of these shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2018 Filed Feb 20, 2018 14:35 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 5,261,410 | $19.31 | $101,597,827.10 |
DisclosureSEC source: 0001140361-18-008926 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares were indirectly sold to the Amandla MK Trust in return for a promissory note. Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 21:11 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass B Common Stock | 1,602,399 | $39.03 | $62,541,632.97 |
DisclosureSEC source: 0001140361-18-003552 · doc1.xml · nonDerivative · entry 5 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares were sold to the Amandla MK Trust in return for a promissory note. Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 21:11 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GiftClass B Common Stock | 281,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-003552 · doc1.xml · nonDerivative · entry 4 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,602,399 Read SEC document |
| January 03, 2018 Filed Jan 4, 2018 20:20 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantEmployee Stock Option (right to buy) · Derivative | 5,193 | $0.00 Strike: $36.80 | $0.00 |
DisclosureSEC source: 0001140361-18-000807 · doc1.xml · derivative · entry 19 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,193 Underlying: Class A Common Stock · 5,193 shares Expires 2028-01-03 F12 · derivative.exercise_date: This option becomes fully exercisable on January 3, 2023. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:20 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 21,633 | $0.00 Strike: $7.59 | $0.00 |
DisclosureSEC source: 0001140361-18-000807 · doc1.xml · derivative · entry 9 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 21,633 shares Expires 2018-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option became fully exercisable on January 4, 2013. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:20 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingClass A Common Stock | 10,177 | $36.80 | $374,513.60 |
DisclosureSEC source: 0001140361-18-000807 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,261,410 Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:20 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 21,633 | $7.59 | $164,194.47 |
DisclosureSEC source: 0001140361-18-000807 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,271,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2017 Filed Jan 4, 2018 20:20 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GiftClass B Common Stock | 74,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-000807 · doc1.xml · nonDerivative · entry 6 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,884,205 Read SEC document |
| December 27, 2017 Filed Jan 4, 2018 20:20 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GiftClass B Common Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-000807 · doc1.xml · nonDerivative · entry 5 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,958,205 Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 20:16 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 500,000 | $17.45 | $8,725,000.00 |
DisclosureSEC source: 0001140361-17-008305 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,249,954 Read SEC document |
| January 17, 2017 Filed Jan 18, 2017 22:51 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 4,296 | $18.32 | $78,703.58 |
DisclosureSEC source: 0001140361-17-002196 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,749,954 F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $18.10 to $18.45. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 22:51 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 10,000 | $18.55 | $185,498.00 |
DisclosureSEC source: 0001140361-17-002196 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,754,250 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $18.70 to $18.20. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| January 11, 2017 Filed Jan 13, 2017 20:05 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 700 | $19.00 | $13,300.00 |
DisclosureSEC source: 0001140361-17-001801 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,764,250 Read SEC document |
| January 10, 2017 Filed Jan 10, 2017 23:08 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 3,055 | $19.09 | $58,310.48 |
DisclosureSEC source: 0001140361-17-001408 · doc1.xml · nonDerivative · entry 3 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,764,950 F3 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $19.00 to $19.175. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| January 09, 2017 Filed Jan 10, 2017 23:08 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 1,665 | $19.34 | $32,194.77 |
DisclosureSEC source: 0001140361-17-001408 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,768,005 F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $19.25 to $19.45. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 23:08 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 762 | $19.63 | $14,961.26 |
DisclosureSEC source: 0001140361-17-001408 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,769,670 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $19.60 to $19.75. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| January 04, 2017 Filed Jan 5, 2017 15:55 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantEmployee Stock Option (right to buy) · Derivative | 1,246 | $0.00 Strike: $40.54 | $0.00 |
DisclosureSEC source: 0001140361-17-000613 · doc1.xml · derivative · entry 25 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,246 Underlying: Class B Common Stock · 1,246 shares Expires 2027-01-04 F12 · derivative.exercise_date: This option becomes fully exercisable on January 4, 2022. Read SEC document |
| January 04, 2017 Filed Jan 5, 2017 15:55 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantEmployee Stock Option (right to buy) · Derivative | 7,478 | $0.00 Strike: $18.80 | $0.00 |
DisclosureSEC source: 0001140361-17-000613 · doc1.xml · derivative · entry 19 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,478 Underlying: Class A Common Stock · 7,478 shares Expires 2027-01-04 F12 · derivative.exercise_date: This option becomes fully exercisable on January 4, 2022. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 15:55 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 25,068 | $0.00 Strike: $6.62 | $0.00 |
DisclosureSEC source: 0001140361-17-000613 · doc1.xml · derivative · entry 9 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 25,068 shares Expires 2017-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option became fully exercisable on January 5, 2012. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 15:55 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingClass A Common Stock | 14,392 | $18.80 | $270,569.60 |
DisclosureSEC source: 0001140361-17-000613 · doc1.xml · nonDerivative · entry 3 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,770,432 Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 15:55 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 25,068 | $6.62 | $165,950.16 |
DisclosureSEC source: 0001140361-17-000613 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,784,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2016 Filed Jan 5, 2017 15:55 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GiftClass A Common Stock | 246,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-000613 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,759,756 Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 18:04 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GiftClass A Common Stock | 272,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-089771 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,006,456 Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 00:11 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 101 | $16.00 | $1,616.00 |
DisclosureSEC source: 0001140361-16-088450 · doc1.xml · nonDerivative · entry 3 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,279,178 Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 00:11 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 83,539 | $16.00 | $1,336,624.00 |
DisclosureSEC source: 0001140361-16-088450 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,279,279 Read SEC document |
| November 29, 2016 Filed Dec 2, 2016 00:11 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 3,370 | $16.00 | $53,920.00 |
DisclosureSEC source: 0001140361-16-088450 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,362,818 Read SEC document |
| November 28, 2016 Filed Nov 28, 2016 23:06 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 6,058 | $16.00 | $96,928.00 |
DisclosureSEC source: 0001140361-16-087983 · doc1.xml · nonDerivative · entry 3 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,366,188 Read SEC document |
| November 25, 2016 Filed Nov 28, 2016 23:06 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 3,696 | $16.00 | $59,136.00 |
DisclosureSEC source: 0001140361-16-087983 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,372,246 Read SEC document |
| November 23, 2016 Filed Nov 28, 2016 23:06 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 3,331 | $16.00 | $53,296.00 |
DisclosureSEC source: 0001140361-16-087983 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,375,942 Read SEC document |
| November 22, 2016 Filed Nov 22, 2016 22:42 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 7,999 | $16.00 | $127,984.00 |
DisclosureSEC source: 0001140361-16-087630 · doc1.xml · nonDerivative · entry 3 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,379,273 Read SEC document |
| November 21, 2016 Filed Nov 22, 2016 22:42 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 11,569 | $16.02 | $185,335.38 |
DisclosureSEC source: 0001140361-16-087630 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,387,272 Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 22:42 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 8,441 | $16.03 | $135,309.23 |
DisclosureSEC source: 0001140361-16-087630 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,398,841 Read SEC document |
| November 17, 2016 Filed Nov 17, 2016 23:18 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 5,629 | $16.01 | $90,120.29 |
DisclosureSEC source: 0001140361-16-087127 · doc1.xml · nonDerivative · entry 3 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,407,282 Read SEC document |
| November 16, 2016 Filed Nov 17, 2016 23:18 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 14,430 | $16.00 | $230,880.00 |
DisclosureSEC source: 0001140361-16-087127 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,412,911 Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 23:18 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 4,775 | $16.06 | $76,686.50 |
DisclosureSEC source: 0001140361-16-087127 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,427,341 Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 17:00 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 6,983 | $16.00 | $111,728.00 |
DisclosureSEC source: 0001140361-16-086692 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,432,116 Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 17:00 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 11,745 | $16.06 | $188,624.70 |
DisclosureSEC source: 0001140361-16-086692 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,439,099 Read SEC document |
| September 27, 2016 Filed Sep 29, 2016 21:29 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 3,675 | $16.00 | $58,800.00 |
DisclosureSEC source: 0001140361-16-081087 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,450,844 Read SEC document |
| September 26, 2016 Filed Sep 26, 2016 21:40 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 1 | $16.00 | $16.00 |
DisclosureSEC source: 0001140361-16-080752 · doc1.xml · nonDerivative · entry 3 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,454,519 Read SEC document |
| September 23, 2016 Filed Sep 26, 2016 21:40 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 3,301 | $16.03 | $52,915.03 |
DisclosureSEC source: 0001140361-16-080752 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,454,520 Read SEC document |
| September 22, 2016 Filed Sep 26, 2016 21:40 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 6,983 | $16.01 | $111,797.83 |
DisclosureSEC source: 0001140361-16-080752 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,457,821 Read SEC document |
| September 21, 2016 Filed Sep 21, 2016 20:52 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 1,440 | $16.01 | $23,054.40 |
DisclosureSEC source: 0001140361-16-080429 · doc1.xml · nonDerivative · entry 3 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,464,804 Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 20:52 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 1,500 | $16.28 | $24,420.00 |
DisclosureSEC source: 0001140361-16-080429 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,466,244 Read SEC document |
| September 19, 2016 Filed Sep 21, 2016 20:52 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 3,533 | $16.19 | $57,199.27 |
DisclosureSEC source: 0001140361-16-080429 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,467,744 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.